1. Home
  2. AKTX vs DLPN Comparison

AKTX vs DLPN Comparison

Compare AKTX & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

SELL

Current Price

$7.18

Market Cap

15.4M

Sector

Health Care

ML Signal

SELL

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

N/A

Current Price

$0.86

Market Cap

13.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
AKTX
DLPN
Founded
N/A
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
13.4M
IPO Year
2014
2008

Fundamental Metrics

Financial Performance
Metric
AKTX
DLPN
Price
$7.18
$0.86
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $25.50
N/A
AVG Volume (30 Days)
★ 32.2K
12.4K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 77.87
EPS
★ N/A
N/A
Revenue
N/A
★ $56,699,389.00
Revenue This Year
N/A
$4.88
Revenue Next Year
N/A
$3.25
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 9.70
52 Week Low
$0.12
$0.83
52 Week High
$29.32
$1.87

Technical Indicators

Market Signals
Indicator
AKTX
DLPN
Relative Strength Index (RSI) 42.25 37.91
Support Level $5.01 N/A
Resistance Level $9.91 $1.08
Average True Range (ATR) 0.90 0.07
MACD -0.06 -0.01
Stochastic Oscillator 24.25 8.27

Price Performance

Historical Comparison
AKTX
DLPN

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

Share on Social Networks: